Physician profile
David Christ
NPI 1922072297
$1,012.04
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $209 · 2021: $167 · 2022: $178 · 2023: $120 · 2024: $81.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $264.83 | 2019-2023 | Lupron Depot |
| Janssen Biotech, INC. | $142.35 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $91.49 | 2019-2023 | Edex, Xiaflex, Aveed |
| Amgen INC. | $91.08 | 2020-2023 | Xgeva |
| Astellas Pharma US INC | $66.60 | 2019-2022 | |
| Procept Biorobotics Corporation | $46.69 | 2024 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $42.48 | 2019 | |
| Blue Earth Diagnostics | $38.94 | 2021 | |
| Karl Storz Endoscopy-America | $35.78 | 2019 | |
| Boston Scientific Corporation | $30.25 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $29.05 | 2022 | |
| Coloplast Corp | $26.51 | 2020-2021 | |
| Convatec INC. | $24.15 | 2023 | |
| Urogen Pharma, INC. | $22.02 | 2024 | |
| Biotissue Holdings INC. | $19.16 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.16 | 2023 | |
| Endo USA, INC. | $13.08 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Christ listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.